The Latin America, Middle East and Africa Insomnia Market would witness market growth of 9.8% CAGR during the forecast period (2022-2028).
Numerous physical and mental health conditions and insomnia are related to one another. Consistent sleep deprivation raises the risk for diseases like high blood pressure, heart disease, diabetes, and chronic pain. In addition to prescription medicines, over-the-counter medicines can also cause insomnia. Consulting the doctor for advice on how to treat the condition or medication, as well as the sleep issues, if it has been proven that it causes insomnia is crucial. Without treatment, insomnia is not likely to get better.
Many adults eventually go through short-term or acute insomnia, which can last for days or weeks. Typically, stress or a traumatic event is the cause. However, some people experience chronic long-term sleep disorder that lasts for a month or even longer. The main issue might be insomnia, or it might also be related to other illnesses or medications. To find out the cause of the sleep disorder & how to treat it, consulting a doctor is essential.
The average amount of sleep time for study participants was 5 hours and 24 minutes, which is significantly less than the amount of time suggested by sleep standards. The study's findings also revealed a strong correlation between total sleep time & overall sleep quality with excitement. Future research should concentrate on methods to enhance the quality of sleep and elements that influence the effectiveness of sleep. The insomnia market is expanding in this region due to the rising incidence of insomnia among students.
The Brazil market dominated the LAMEA Insomnia Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $126.4 million by 2028. The Argentina market is exhibiting a CAGR of 10.4% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 9.5% during (2022 - 2028).
Based on Distribution Channel, the market is segmented into Hospital, Retail, and Others. Based on Therapy Type, the market is segmented into Pharmacological and Non-Pharmacological.Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Insomnia Market is Predict to reach $5.7 Billion by 2028, at a CAGR of 3.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Currax Pharmaceuticals LLC (Currax Holdings USA LLC), Eisai Co., Ltd., Merck Group, Pfizer, Inc., Vanda Pharmaceuticals, Inc., Cadila Healthcare Ltd. (Zydus Cadila), Sanofi S.A., Viatris, Inc., Takeda Pharmaceutical Company Limited, and Purdue Pharma L.P.
By Distribution Channel
By Therapy Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
